Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.

There is no effective treatment for the prevalent chronic form of Chagas' disease in Latin America. Its causative agent, the protozoan parasite Trypanosoma cruzi, has an essential requirement for ergosterol, and ergosterol biosynthesis inhibitors, such as the antifungal drug posaconazole, have potent trypanocidal activity. The antiarrhythmic compound amiodarone, frequently prescribed for the symptomatic treatment of Chagas' disease patients, has also recently been shown to have antifungal activity. We now show here for the first time that amiodarone has direct activity against T. cruzi, both in vitro and in vivo, and that it acts synergistically with posaconazole. We found that amiodarone, in addition to disrupting the parasites' Ca(2+) homeostasis, also blocks ergosterol biosynthesis, and that posaconazole also affects Ca(2+) homeostasis. These results provide logical explanations for the synergistic activity of amiodarone with azoles against T. cruzi and open up the possibility of novel, combination therapy approaches to the treatment of Chagas' disease using currently approved drugs.

[1]  J. C. Hinshaw,et al.  Oxidosqualene cyclase inhibitors as antimicrobial agents. , 2003, Journal of medicinal chemistry.

[2]  W. de Souza,et al.  Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi , 1991, Antimicrobial Agents and Chemotherapy.

[3]  G. Schulz,et al.  Binding structures and potencies of oxidosqualene cyclase inhibitors with the homologous squalene-hopene cyclase. , 2003, Journal of medicinal chemistry.

[4]  Suggested guidelines for work with live Trypanosoma cruzi. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[5]  A. De Maio,et al.  Trypanosoma (Schizotrypanum) cruzi: terminal oxidases in exponential and stationary growth phase emipastigotes cultured in vitro. , 1984, Acta cientifica venezolana.

[6]  D. Loebenberg,et al.  Activities of the Triazole Derivative SCH 56592 (Posaconazole) against Drug-Resistant Strains of the Protozoan ParasiteTrypanosoma (Schizotrypanum) cruzi in Immunocompetent and Immunosuppressed Murine Hosts , 2000, Antimicrobial Agents and Chemotherapy.

[7]  R. Favaloro,et al.  Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas' heart disease patient. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  D S Goodsell,et al.  Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.

[9]  A. Rassi,et al.  Chagas' Heart Disease , 2000, Clinical cardiology.

[10]  AMIODARONE , 1979, The Lancet.

[11]  H. Hallander,et al.  Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method , 1982, Antimicrobial Agents and Chemotherapy.

[12]  R. Dipolo,et al.  Evaluation of the Presence of a Thapsigargin-Sensitive Calcium Store in Trypanosomatids Using Trypanosoma evansi as a Model , 2004, The Journal of parasitology.

[13]  Sedide B. Ozturk,et al.  Amiodarone induces a caffeine‐inhibited, MID1‐depedent rise in free cytoplasmic calcium in Saccharomyces cerevisiae , 2002, Molecular microbiology.

[14]  R. Dipolo,et al.  Ceramide increase cytoplasmic Ca2+ concentration in Jurkat T cells by liberation of calcium from intracellular stores and activation of a store-operated calcium channel. , 2005, Archives of biochemistry and biophysics.

[15]  P. Wincker,et al.  Cure of Short- and Long-Term Experimental Chagas' Disease Using D0870 , 1996, Science.

[16]  J. Dias.  Control of Chagas disease in Brazil. , 1987, Parasitology today.

[17]  W. Courchesne.  Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone. , 2002, The Journal of pharmacology and experimental therapeutics.

[18]  M. Ward,et al.  Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts , 2000, Trends in Neurosciences.

[19]  W. de Souza,et al.  Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi , 1990, Antimicrobial Agents and Chemotherapy.

[20]  Y. Yamagata,et al.  Control of Chagas disease. , 2006, Advances in parasitology.

[21]  E. Oldfield,et al.  Bisphosphonates Are Potent Inhibitors of Trypanosoma cruzi Farnesyl Pyrophosphate Synthase* , 2001, The Journal of Biological Chemistry.

[22]  J. Urbina,et al.  Specific chemotherapy of Chagas disease: controversies and advances. , 2003, Trends in parasitology.

[23]  J. Concepción,et al.  In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi , 2004, Antimicrobial Agents and Chemotherapy.

[24]  Y. Paik,et al.  Pharmacological Analysis of Sterol Δ8-Δ7 Isomerase Proteins with [3H]Ifenprodil , 1998 .

[25]  P. Wincker,et al.  Antiproliferative Effects and Mechanism of Action of SCH 56592 against Trypanosoma (Schizotrypanum)cruzi: In Vitro and In Vivo Studies , 1998, Antimicrobial Agents and Chemotherapy.

[26]  E. Krajewska-Kułak,et al.  Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro. , 1993, Arzneimittel-Forschung.

[27]  R. Courtney,et al.  Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults , 2003, Antimicrobial Agents and Chemotherapy.

[28]  J. Concepción,et al.  Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana. , 2002, Molecular and biochemical parasitology.

[29]  P. Verweij,et al.  Potent Synergistic In Vitro Interaction between Nonantimicrobial Membrane-Active Compounds and Itraconazole against Clinical Isolates of Aspergillus fumigatus Resistant to Itraconazole , 2004, Antimicrobial Agents and Chemotherapy.

[30]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[31]  E. H. Fife.  4 – Trypanosoma (Schizotrypanum) cruzi , 1977 .

[32]  T. Schulz-Gasch,et al.  Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase , 2004, Nature.

[33]  D. Loebenberg,et al.  Posaconazole Is a Potent Inhibitor of Sterol 14α-Demethylation in Yeasts and Molds , 2004, Antimicrobial Agents and Chemotherapy.

[34]  Veronica G. Beaudry,et al.  Antifungal Activity of Amiodarone Is Mediated by Disruption of Calcium Homeostasis* , 2003, Journal of Biological Chemistry.